Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masmudur M Rahman

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2016
Myxoma virus M156 is a specific inhibitor of rabbit PKR but contains a loss-of-function mutation in Australian virus isolatesChen Peng, Sherry L Haller, Masmudur M Rahman, et al.
Virology|February 24, 2009
Interaction of human TNF and beta2-microglobulin with Tanapox virus-encoded TNF inhibitor, TPV-2LMasmudur M Rahman, David Jeng, Rajkumari Singh, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 27, 2020
Methods for the Construction of Recombinant Oncolytic Myxoma VirusesLino E Torres-Domínguez, Ana Lemos de Matos, Masmudur M Rahman, et al.
International Journal of Molecular Sciences|October 26, 2024
Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood-Brain Barrier and Treat Murine GliomaJoanna Jazowiecka-Rakus, Kinga Pogoda-Mieszczak, Masmudur M Rahman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 12, 2012
Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancerSonia Tusell Wennier, Jia Liu, Shoudong Li, et al.
Viruses|August 28, 2025
The Role of Myxoma Virus Immune Modulators and Host Range Factors in Pathogenesis and Species LeapingJunior A Enow, Ana M Lopes, Joana Abrantes, et al.
Molecular Therapy Oncolytics|October 27, 2018
Oncolytic Virus-Mediated RAS Targeting in RhabdomyosarcomaMichael P Phelps, Heechang Yang, Shivani Patel, et al.
Current Protocols in Microbiology|May 4, 2011
Production of Myxoma virus gateway entry and expression libraries and validation of viral protein expressionSherin E Smallwood, Masmudur M Rahman, Steven J Werden, et al.
Journal of Virology|May 6, 2021
RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer CellsMasmudur M Rahman, Ami D Gutierrez-Jensen, Honor L Glenn, et al.
Journal of Virology|July 3, 2009
Cowpox virus expresses a novel ankyrin repeat NF-kappaB inhibitor that controls inflammatory cell influx into virus-infected tissues and is critical for virus pathogenesisMohamed Ragaa Mohamed, Masmudur M Rahman, Amanda Rice, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2016
Myxoma virus M156 is a specific inhibitor of rabbit PKR but contains a loss-of-function mutation in Australian virus isolatesChen Peng, Sherry L Haller, Masmudur M Rahman, et al.
Virology|February 24, 2009
Interaction of human TNF and beta2-microglobulin with Tanapox virus-encoded TNF inhibitor, TPV-2LMasmudur M Rahman, David Jeng, Rajkumari Singh, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 27, 2020
Methods for the Construction of Recombinant Oncolytic Myxoma VirusesLino E Torres-Domínguez, Ana Lemos de Matos, Masmudur M Rahman, et al.
International Journal of Molecular Sciences|October 26, 2024
Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood-Brain Barrier and Treat Murine GliomaJoanna Jazowiecka-Rakus, Kinga Pogoda-Mieszczak, Masmudur M Rahman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 12, 2012
Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancerSonia Tusell Wennier, Jia Liu, Shoudong Li, et al.
Viruses|August 28, 2025
The Role of Myxoma Virus Immune Modulators and Host Range Factors in Pathogenesis and Species LeapingJunior A Enow, Ana M Lopes, Joana Abrantes, et al.
Molecular Therapy Oncolytics|October 27, 2018
Oncolytic Virus-Mediated RAS Targeting in RhabdomyosarcomaMichael P Phelps, Heechang Yang, Shivani Patel, et al.
Current Protocols in Microbiology|May 4, 2011
Production of Myxoma virus gateway entry and expression libraries and validation of viral protein expressionSherin E Smallwood, Masmudur M Rahman, Steven J Werden, et al.
Journal of Virology|May 6, 2021
RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer CellsMasmudur M Rahman, Ami D Gutierrez-Jensen, Honor L Glenn, et al.
Journal of Virology|July 3, 2009
Cowpox virus expresses a novel ankyrin repeat NF-kappaB inhibitor that controls inflammatory cell influx into virus-infected tissues and is critical for virus pathogenesisMohamed Ragaa Mohamed, Masmudur M Rahman, Amanda Rice, et al.
Pageof 9